Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Neuroimage. Clinical|November 22, 2017
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's DiseaseLeonardo Iaccarino, Gautam Tammewar, Nagehan Ayakta, et al.
Vaccine|March 6, 2014
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine releasePetr O Ilyinskii, Christopher J Roy, Conlin P O'Neil, et al.
Neurology|December 29, 2017
Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Brain : a Journal of Neurology|March 11, 2016
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's diseaseRik Ossenkoppele, Daniel R Schonhaut, Michael Schöll, et al.
Neurology|December 20, 2013
Practical utility of amyloid and FDG-PET in an academic dementia centerPascual Sánchez-Juan, Pia M Ghosh, Jayne Hagen, et al.
Neurology|December 2, 2011
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLDG D Rabinovici, H J Rosen, A Alkalay, et al.
JAMA Neurology|January 9, 2018
Rates of Amyloid Imaging Positivity in Patients With Primary Progressive AphasiaMiguel A Santos-Santos, Gil D Rabinovici, Leonardo Iaccarino, et al.
Alzheimer'S Research & Therapy|February 2, 2019
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Vaccine|May 2, 2002
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccineRama Rao Amara, Francois Villinger, John D Altman, et al.
Science Translational Medicine|January 3, 2020
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PETRenaud La Joie, Adrienne V Visani, Suzanne L Baker, et al.
Pageof 18